FI5176U1 - Sitalopraamia sisältävä farmaseuttinen koostumus - Google Patents

Sitalopraamia sisältävä farmaseuttinen koostumus

Info

Publication number
FI5176U1
FI5176U1 FI20010303U FIU20010303U FI5176U1 FI 5176 U1 FI5176 U1 FI 5176U1 FI 20010303 U FI20010303 U FI 20010303U FI U20010303 U FIU20010303 U FI U20010303U FI 5176 U1 FI5176 U1 FI 5176U1
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
composition containing
containing citalopram
citalopram
pharmaceutical
Prior art date
Application number
FI20010303U
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Swen Wagner
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI5176(U1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of FI5176U1 publication Critical patent/FI5176U1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20010303U 2000-08-10 2001-08-09 Sitalopraamia sisältävä farmaseuttinen koostumus FI5176U1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (1)

Publication Number Publication Date
FI5176U1 true FI5176U1 (fi) 2001-12-27

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20010303U FI5176U1 (fi) 2000-08-10 2001-08-09 Sitalopraamia sisältävä farmaseuttinen koostumus

Country Status (34)

Country Link
EP (1) EP1318805A2 (ja)
JP (1) JP2003531153A (ja)
KR (1) KR20030024833A (ja)
CN (1) CN1446089A (ja)
AR (1) AR030095A1 (ja)
AT (1) AT5744U1 (ja)
AU (2) AU2001100198B4 (ja)
BE (1) BE1013559A6 (ja)
BG (1) BG107578A (ja)
BR (1) BR0113250A (ja)
CA (1) CA2353693C (ja)
CH (2) CH694241A5 (ja)
CZ (1) CZ2003397A3 (ja)
DE (2) DE20113195U1 (ja)
EA (1) EA200300247A1 (ja)
ES (1) ES2172481B2 (ja)
FI (1) FI5176U1 (ja)
FR (1) FR2812811B1 (ja)
GB (1) GB2368014B (ja)
GR (1) GR1004193B (ja)
HR (1) HRP20030054A2 (ja)
HU (1) HUP0103071A3 (ja)
IE (1) IES20010693A2 (ja)
IL (1) IL154050A0 (ja)
IS (1) IS6021A (ja)
IT (1) ITMI20011637A1 (ja)
MX (1) MXPA03000837A (ja)
NL (1) NL1018741C1 (ja)
NO (1) NO20013891L (ja)
NZ (1) NZ523785A (ja)
PL (1) PL359824A1 (ja)
SK (1) SK2842003A3 (ja)
WO (1) WO2001080619A2 (ja)
YU (1) YU9003A (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
MXPA05005772A (es) * 2002-12-23 2005-08-16 Lundbeck & Co As H Bromhidrato de escitalopram y un metodo para su preparacion.
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480192A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
CN106397249A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种高稳定性lcz696结晶粉末及其制备方法
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
IES20010693A2 (en) 2002-07-10
CH694241A5 (de) 2004-10-15
EP1318805A2 (en) 2003-06-18
WO2001080619A3 (en) 2002-02-21
AT5744U1 (de) 2002-11-25
JP2003531153A (ja) 2003-10-21
SK2842003A3 (en) 2003-09-11
CA2353693C (en) 2003-07-22
EA200300247A1 (ru) 2003-06-26
IL154050A0 (en) 2003-07-31
FR2812811A1 (fr) 2002-02-15
HUP0103071A2 (hu) 2002-05-29
MXPA03000837A (es) 2003-06-06
FR2812811B1 (fr) 2006-08-18
WO2001080619A2 (en) 2001-11-01
AU2001100198A4 (en) 2001-08-16
AU2001100198B4 (en) 2002-06-13
DE20113195U1 (de) 2001-11-15
NO20013891D0 (no) 2001-08-09
ES2172481A1 (es) 2002-09-16
GR20010100377A (el) 2002-09-06
PL359824A1 (en) 2004-09-06
CZ2003397A3 (cs) 2003-06-18
GB2368014A (en) 2002-04-24
AU2001279591A1 (en) 2001-11-07
BE1013559A6 (fr) 2002-03-05
KR20030024833A (ko) 2003-03-26
AR030095A1 (es) 2003-08-13
CA2353693A1 (en) 2002-01-22
HU0103071D0 (en) 2001-10-28
NO20013891L (no) 2002-02-11
HRP20030054A2 (en) 2005-02-28
IS6021A (is) 2001-10-20
CH694242A5 (de) 2004-10-15
GR1004193B (el) 2003-03-24
GB2368014B (en) 2004-06-23
HUP0103071A3 (en) 2002-12-28
NZ523785A (en) 2004-09-24
GB0118579D0 (en) 2001-09-19
DE10139115A1 (de) 2002-03-28
BR0113250A (pt) 2003-06-24
ES2172481B2 (es) 2004-08-01
NL1018741C1 (nl) 2002-02-12
ITMI20011637A1 (it) 2003-01-27
ITMI20011637A0 (it) 2001-07-27
CN1446089A (zh) 2003-10-01
BG107578A (bg) 2003-09-30
YU9003A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
DK1524266T3 (da) Farmaceutisk sammensætning
NO20025450L (no) Ny farmasöytisk sammensetning
PT1307264E (pt) Nova composicao farmaceutica
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
NO20015175L (no) Farmasöytisk sammensetning
FI991485A0 (fi) Uusi farmaseuttinen koostumus
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
ATE330937T1 (de) Glyburid-zusammensetzung
NO20026123L (no) Farmasöytiske sammensetninger
FI5176U1 (fi) Sitalopraamia sisältävä farmaseuttinen koostumus
ATE366128T1 (de) Pharmazeutische zusammensetzung
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
NO20033073L (no) Farmasöytisk sammensetning inneholdende citalopram
EE200300378A (et) Farmatseutiline kompositsioon
DK200100203U4 (da) Farmaceutisk komposition indeholdende citalopram
EE200200689A (et) Ravimkoostised
SE9904819D0 (sv) A new pharmaceutical composition
SE9804128D0 (sv) A new pharmaceutical composition
GB0219820D0 (en) Pharmaceutical compostion containing citalopram